Publications

Design of Chemical Conjugate for Targeted Therapy of Multiple Sclerosis Based of Constant Fragment of Human Antibody Heavy Chain and Peptoid Analog of Autoantigen MOG35-55. Lomakin Y.A., Stepanov A.V., Balabashin D.S., Ponomarenko N.A., Smirnov I.V., Belogurov A.A. Jr. Bull Exp Biol Med. 2017 Apr;162(6):777-780. doi: 10.1007/s10517-017-3711-4. Epub 2017 Apr 21

Exposure to the Epstein-Barr viral antigen LMP1 induces myelin-reactive antibodies in vivo. Yakov Lomakin, Georgii Arapidi, Alexander Chernov, Rustam Ziganshin, Evgenii Tcyganov, Irina Lyadova, Ivan Butenko, Maria Osetrova, Natalia Ponomarenko, Georgy Telegin, Vadim Govorun, Alexander Gabibov, Alexey Belogurov Jr. Frontiers in Immunology, 2017

 Peptides against autoimmune neurodegeneration.Stepanov A, Lomakin Y, Gabibov A, Belogurov A. Curr Med Chem. 2017 Jun 4. doi: 10.2174/0929867324666170605092221

Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism. Kuzina E.S., Kudriaeva A.A., Glagoleva I.S., Knorre V.D., Gabibov A.G., Belogurov A.A. Dokl Biochem Biophys. 2016 Jul;469(1):277-80

mRNA expression profile of mouse oligodendrocytes in inflammatory conditions. Kudriaeva A.A., Khaustova N.A., Maltseva D.V., Kuzina E.S., Glagoleva I.S., Surina E.A., Knorre V.D., Belogurov A.A. Jr, Tonevitsky A.G., Gabibov A.G. Dokl Biochem Biophys. 2016 Jul;469(1):264-8.

CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study. Belogurov A. Jr, Zakharov K., Lomakin Y., Surkov K., Avtushenko S., Kruglyakov P., Smirnov I., Makshakov G., Lockshin C., Gregoriadis G.,Genkin D., Gabibov A., Evdoshenko E. Neurotherapeutics. 2016 Jun 20.

Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects. Kuzina E.S., Kudriaeva A.A., Maltseva D.V., Belogurov A.A. Jr. Bull Exp Biol Med. 2016 May;161(1):69-71.

Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1. Mamedov A.E., Ponomarenko N.A., Belogurov A.A. Jr, Gabibov A.G. Bull Exp Biol Med. 2016 May;161(1):92-5.

Noggin4 is a long-range inhibitor of Wnt8 signalling that regulates head development in Xenopus laevis. Eroshkin F.M., Nesterenko A.M., Borodulin A.V., Martynova N.Y., Ermakova G.V., Gyoeva F.K., Orlov E.E., Belogurov A.A., Lukyanov K.A., Bayramov A.V., Zaraisky A.G. Sci Rep. 2016 Mar 14;6:23049

Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers. Terekhov S.S., Smirnov I.V., Shamborant O.G., Bobik T.V., Ilyushin D.G., Murashev A.N., Dyachenko I.A., Palikov V.A., Knorre V.D., Belogurov A.A., Ponomarenko N.A., Kuzina E.S., Genkin D.D., Masson P., Gabibov A.G. Acta Naturae. 2015 Oct-Dec;7(4):136-41

Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.

Lomakin Y., Belogurov A. Jr, Glagoleva I., Stepanov A., Zakharov K., Okunola J., Smirnov I., Genkin D., Gabibov A.

Mediators Inflamm. 2016;2016:2847232.